Authorities misinterpreting COVID-19 trial data with ‘disastrous’ results, Canadian researchers say

Article content continued The episode was typical of what has become a serious problem in the COVID-19 pandemic: misinterpretation of trial data, with “disastrous” results for other studies, Mills and colleagues argue in a recent medical journal commentary. Influenced by media accounts, scientific oversight boards often don’t recognize there are distinct phases to COVID-19 sickness,… Read More »

Mylan boosts Euro portfolio with $756M rights deal for Aspen’s injectable thrombosis meds

Mylan’s planned megamerger with Pfizer’s Upjohn generics unit has had a rocky road to approval, with the novel coronavirus pandemic snagging regulatory review. Despite the delay, Mylan isn’t twiddling its thumbs: The generics giant is now bolting on a major addition to its EU portfolio as it awaits its merger deadline. Mylan will shell out… Read More »